Cardiorenalmetabolic

Latest News

Christian Ruff, MD
Dr Ruff Explores Mitigating Surgical Bleeding in AFib With Abelacimab

February 6th 2025

Favorable bleeding outcomes related to abelacimab have positioned the medication as a potential game changer in the treatment of atrial fibrillation.

Conceptualizing reduced cost and increased value | image credit: patpitchaya - stock.adobe.com
Polypill Treatment: A Clinically Effective and Cost-Saving Strategy for CVD Management

February 3rd 2025

Hand holding green apple surrounded by micronutrient names | Image credit: mi_viri – stock.adobe.com
Most Patients With Type 2 Diabetes Have Vitamin D Deficiency, Study Suggests

January 28th 2025

Atrial fibrillation | image credit: Uladzlislau - stock.adobe.com
Abelacimab, a “Game Changer” for High-Risk Patients With AFib: Dr Ruff and Dr Bloomfield Elaborate on Latest Data From AZALEA-TIMI 71 Trial

January 22nd 2025

AJMC
Physiologic Insulin Resensitization Lowers Cost in Patients With Diabetes and Kidney Disease

January 17th 2025

More News

AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo